CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 343 participants.
Also called NCT03455725
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 343 participants
- Sponsor
- BioCardia, Inc.
- Registry
-
NCT03455725
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03455725. Randomized; quadruple masking; primary purpose treatment. Start 2021-06-30 (actual); primary completion 2025-02-19 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial
- Acronym
- CardiAMP-CMI
- Condition
- Refractory Angina
- Condition
- Chronic Myocardial Ischemia
- Intervention (Device)
- CardiAMP Cell Therapy System
- Intervention (Other)
- Sham Treatment
- Lead sponsor
- BioCardia, Inc.
Record details
- Record id
cardio:ct-nct03455725- Content hash
798fb1d462dcdd14597b741b544a47425a6a2bb0f8296355e09caed8246858bf